Author(s): Vaibhav V. Kakade, Ravindra B. Laware


DOI: 10.52711/0975-4377.2024.00011   

Address: Vaibhav V. Kakade1*, Ravindra B. Laware2
1Research Scholar Bhagwant University, Ajmer, Rajasthan.
2Professor and Principal College of Pharmaceutical Sciences, Pravara Institute of Medical Sciences, Loni.
*Corresponding Author

Published In:   Volume - 16,      Issue - 1,     Year - 2024

Ellagic acid, a polyphenolic compound present in fruits and berries, with wide spectrum of therapeutic and prophylactic activities. It has wide spectrum of therapeutic, prophylactic and nutritional activities. It is traditionally being used for cosmetic and therapeutic purposes for treating hyperpigmentation, skin cancer and many other skin ailments. Unfortunately Ellagic acid suffers from disadvantages of poor solubility, stability, bioavailability, first pass effect and inter subject variability in gut metabolism. This put serious limit over its use as a therapeutic agent. Recently a focus is being made on improving EA delivery to the site of action using various novel drug delivery systems. Presenting EA topically in vesicular drug delivery as niosomes using natural penetration enhancer as almond oil or olive oil can improve its water solubility and transdermal penetration. It was also learned during literature survey that niosomes act as a good delivery system for hydrophobic drug and serve to increase their dermal penetration. Niosomal gel increases formulation stability and offer to increase drug penetration further and achieve controlled release drug delivery. Literature survey revealed that essential oils as olive, almond or mustard oil act as good natural penetration enhancer for drug in trasndermal gel formulation.

Cite this article:
Vaibhav V. Kakade, Ravindra B. Laware. A Review on Formulation Aspects of Niosomal Gel of Ellagic Acid using Natural Penetration Enhancers. Research Journal of Pharmaceutical Dosage Forms and Technology.2024; 16(1):60-66. doi: 10.52711/0975-4377.2024.00011

Vaibhav V. Kakade, Ravindra B. Laware. A Review on Formulation Aspects of Niosomal Gel of Ellagic Acid using Natural Penetration Enhancers. Research Journal of Pharmaceutical Dosage Forms and Technology.2024; 16(1):60-66. doi: 10.52711/0975-4377.2024.00011   Available on:

1.    Ravi Kumar, S.K., Shyam Shankar Jha, Amit Kumar Jha, Vesicular System-Carrier for Drug Delivery. Pelagia Research Library. 2011. 02(04): p. 192-202.
2.    A.S. Panwar, N. Upadhyay, M. Bairagi, S. Gujar, G.N. Darwhekar, D. K. Jain. Emulgel: A Review. Asian J Pharmacy and life Sci 2011; 1(3): 333-343.
3.    Singh R, Parpani S, Narke R and Chavan R: Emulgel: A Recent Approach for Topical Drug Delivery System. Asian Journal of Pharmaceutical Research and Development. 2014; 2(2): 112-23.
4.    Talegaonkar, S., et al., Vesicular systems: An overview. Indian Journal of Pharmaceutical Sciences. 2006; 68(2): 141.
5.    Shakya V. Niosomes: A Novel Trend in Drug Delivery. IJRDP. 2014; 3: 1036-1041.
6.    Bagheri A, Chu B, Yaakob H. Niosomal Drug Delivery Systems: Formulation, Preparation and Applications. World Applied Sciences Journal. 2014; 32: 1671-1685.
7.    Sudheer P, Kaushik K. Review on Niosomes- A Novel Approach for Drug Targeting, Journal of Pharmaceutical Research. 2015; 1-14.
8.    Sunilkumar M. Niosomes As novel drug delivery system. International Research Journal of Pharmaceutical and Applied Science. 2015; 5: 1-7.
9.    Sanjay, Jain BD, Padsalg A, Patel K and Mokale V: Formulation, development and evaluation of Fluconazole gel in various polymer bases, Asian. J. Pharm. 2007; 1: 63-68.
10.    Makeshwar KB, Wasankar SR. Niosome: a novel drug delivery system. Asian J. Pharm. Res. 2013; 3(1): 16-20.
11.    Mohamed MI Topical emulsion- gel composition comprising diclofenac sodium. AAPS Journal. 2004; 6(3).
12.    Bouwstra JA, Honeywell-Nguyen PL. Skin structure and mode of action of vesicles. Adv Drug Deliv Rev. 2002; 54: 41–55.
13.    Manconi M, Sinico C, Valenti D, Lai F, Fadda AM. Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin. Int J Pharm. 2006; 27: 11–19.
14.    Chandu VP. Niosomes: A novel drug delivery system. International Journalof Novel Trends in Pharmaceutical Sciences, 2012; 2(1): 25-31.
15.    Gandhi A, Sen S, Paul A. Current trends in noisome as vesicular drug delivery system. Asian Journal of Pharmacy and Life Science. 2012; 2(2):339-353.
16.    Madhav NVS, Saini A. Niosomes: A Novel Drug Delivery System. IJRPC 2011; 1(3): 498-511.
17.    Das K, Ram A. Niosome as a novel drug delivery system A review. International Journal of Applied Pharmaceutics, 2013; 6(1): 1-7.
18.    Raza R, Ashu M, Kumar P, Alam S, Prakash S, Chauhan N. Approaches and evaluation of transdermal drug delivery. Int J Drug Dev Res. 2015; 7(1): 222-33.
19.    Dhamecha D, Rathi AA, Saifee M, Lahoti SR, Dehghan HG. Drug vehicle based approaches of penetration enhancement. Int J Pharm Pharm Sci. 2009; 1(1): 24-46.
20.    Mohamed MI. Optimization of Cholrphensin emulgel formulation. AAPS Journal. 2004;6:(26).
21.    Jaydatt KJ, Sreenivas SA. Review on chemical permeation enhances used in transdermal drug delivery system. Int J SciInnovDiscov. 2012; 2: 204-17.
22.    Pfister WR, Hsieh DS. Permeation enhancers compatible with transdermal drug delivery systems. Part I: Selection and formulation considerations. Med Device Technol. 1990; 1: 48-55.
23.    RautVinod S, Nemade S. Lalita, Desai T. Maya, Bonde D. Shailejkumar, Dongare U. Shweta, Chemical Penetration Enhancers: For Transdermal Drug Delivery Systems. 2014: 33-40
24.    Saini S, Chauhan S.K, Agrawal S.S, Recent development in penetration enhancers and techniques in transdermal drug delivery system; Jan-Mar 2014.
25.    Lahor DW, Chaudhary V, Shah KS. Terpenes: Natural skin penetration enhances in transdermal drug delivery system. Int J Pharm Res Dev. 2011; 2(12): 39-45.
26.    Yue Y, Zhao D, Yin Q. Hyaluronic acid modified nanostructured lipid carriers for transdermal bupivacaine delivery: In vitro and in vivo anesthesia evaluation. Biomed Pharmacother. 2018; 98: 813‐820.
27.    Nair VB, Panchagnula R. Effect of iontophoresis and fatty acids on permeation of arginine vasopressin through rat skin. Pharmacol Res. 2003; 47(6): 563‐569.
28.    Cho CW, Choi JS, Yang KH, Shin SC. Enhanced transdermal controlled delivery of glimepiride from the ethylene-vinyl acetate matrix. Drug Deliv. 2009; 16(6):320‐330.
29.    Soler LI, Boix A, Lauroba J, Colom H, Domenech J. Transdermal delivery of alprazolam from a monolithic patch: formulation based on in vitro characterization. Drug DevInd Pharm. 2012; 38(10): 1171‐1178.
30.    Mohamed MI. Optimization of Cholrphensin emulgel formulation. AAPS Journal. 2004; 6: 26.
31.    Kim MJ, Doh HJ, Choi MK, Chung SJ, Shim CK, Kim DD, et al. Skin permeation enhancement of diclofenac by fatty acids. Drug Deliv 2008; 15(6): 373-379.
32.    Malviya V. Design and Characterization of Thermosensitive Mucoadhesive Nasal Gel for Meclizine Hydrochloride. International Journal of Pharmaceutical Sciences and Nanotechnology. 2022; 15(1): 5782-93.
33.    Ahuja Naveen, Katare Om Prakash, and Singh Bhupinder. Studies on dissolution enhacement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers, Int. J. Pharm. 2006; 44-54.
34.    Abd E, Benson HAE, Roberts MS, Grice JE. Follicular Penetration of Caffeine from Topically Applied Nanoemulsion Formulations Containing Penetration Enhancers: In vitro Human Skin Studies. Skin Pharmacol Physiol. 2018; 31(5): 252‐260.
35.    Karpanen TJ, et al. Enhanced chlorhexidine skin penetration with eucalyptus oil. BMC Infect Dis. 2010; 10:278.
36.    Khan NR, et al. Formulation, and physical, in vitro and ex vivo evaluation of transdermal ibuprofen hydrogels containing turpentine oil as penetration enhancer. Pharmazie. 2011; 66: 849-852.
37.    Constantinides P.P. Lipid micro-emulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects, Pharm. Res. 1995; 12; 1561-1572.
38.    Takayama K, Nagai T. Limonene and related compounds as potential skin penetration promoters. Drug DevInd Pharm. 1994; 20: 677-684.
39.    Jain R, et al. Basil oil is a promising skin penetration enhancer for transdermal delivery of labetolol hydrochloride. Drug DevInd Pharm.  2008; 34: 384-389.
40.    Nielsen JB. Natural oils affect the human skin integrity and the percutaneous penetration of benzoic acid dose-dependently. Basic Clin Pharmacol Toxicol. 2006; 98:575-581.
41.    Chiou W., Riegelman S. Preparation and Dissolution Characteristics of Several Fast Release Solid Dispersion of Griseofulvin. J. Pharm. Sci. 1969; 58; 1505.
42.    Malviya V, Burange P, Thakur Y, Tawar M. Enhancement of Solubility and Dissolution Rate of Atazanavir Sulfate by Nanocrystallization. Indian Journal of Pharmaceutical Education and Research. 2021; 55(3):S672-80.
43.    Charoo NA, et al. Improvement in bioavailability of transdermally applied flurbiprofen using tulsi (Ocinum sanctum) and turpentine oil. Colloids Surf B. 2008; 65:300-307.
44.    Kaushal, A.M, Guptam P., and Bansal, AK. Amorphous drug delivery systems: molecular aspects, design, and performance. Crit. Rev. There. Drug Carrier Syst. 2004; 21(3): 133-193.
45.    Rajan R, Vasudevan DT. Effect of permeation enhancers on the penetration mechanism of transfersomal gel of ketoconazole. J Adv Pharm Technol Res. 2012; 3:112-116.
46.    Huang YB, et al. Cardamom oil as a skin permeation enhancer for indomethacin, piroxicam and diclofenac. Int J Pharm. 1995; 126: 111-117.
47.    Wang R, Wu Z, Yang S, et al. A Molecular Interpretation on the Different Penetration Enhancement Effect of Borneol and Menthol towards 5-Fluorouracil. Int J MolSci. 2017; 18(12):2747.
48.    Mohammadi-Samani S, Jamshidzadeh A, Montaseri H, Rangbar- Zahedani M, Kianrad R. The effects of some permeability enhancers on the percutaneous absorption of lidocaine. Pak J Pharm Sci. 2010; 23(1): 83‐88.
49.    Mutalik S, Udupa N. Effect of some penetration enhancers on the permeation of glibenclamide and glipizide through mouse skin. Pharmazie 2003; 58(12): 891‐894.
50.    Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M, Ali A. Role of novel terpenes in transcutaneous permeation of valsartan: effectiveness and mechanism of action. Drug DevInd Pharm. 2011;  37(5): 583‐596.
51.    Charbit G., Badens E., Boutin O. Supercritical Fluid Technology for Drug Product Development, Drugs and Pharmaceutical Sciences. 2004; 138 .
52.    Sapra B, Jain S, Tiwary AK. Effect of Asparagus racemosus extract on transdermal delivery of carvedilol: a mechanistic study. AAPS Pharm Sci Tech. 2009; 10(1):199-210.
53.    Namba T, Sekiya K, Kadota S, Hattori M, Katayama K, Koizumi T. Studies on the baths with crude drug: the effects of Senkyu extract as skin penetration enhancer. Yakugaku Zasshi. 1992; 112(9): 638-644.
54.    Charbit G., Badens E., Boutin O. (2004). Supercritical Fluid Technology for Drug Product Development, Drugs and Pharmaceutical Sciences. 2004; 138.  
55.    Jung J., Perrut M. Particle design using supercritical fluids: literature and patent survey, J. Supercrit. Fluids.2001; 20; 179 219.
56.    Leuner C., Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm. 2000; 50(1): 47 60.
57.    El-Shitany NA, El-Bastawissy EA, El-desoky K. Ellagic acid protects against carrageenan-induced acute inflammation through inhibition of nuclear factor kappa B, inducible cyclooxygenase and proinflammatory cytokines and enhancement of interleukin-10 via an antioxidant mechanism. Int Immunopharmacol. 2014; 19(2): 290-9. doi: 10.1016/j.intimp.2014.02.004. Epub 2014 Feb 15. PMID: 24534771.
58.    Ríos JL, Giner RM, Marín M, Recio MC. A Pharmacological Update of Ellagic Acid. Planta Med. 2018; 84(15): 1068-1093. doi: 10.1055/a-0633-9492. Epub 2018 May 30. PMID: 29847844.
59.    Sharifi-Rad J, Quispe C, Castillo CMS, Caroca R, Lazo-Vélez MA, Antonyak H, Polishchuk A, Lysiuk R, Oliinyk P, De Masi L, Bontempo P, Martorell M, Daştan SD, Rigano D, Wink M, Cho WC. Ellagic Acid: A Review on Its Natural Sources, Chemical Stability, and Therapeutic Potential. Oxid Med Cell Longev. 2022; 2022: 3848084. doi: 10.1155/2022/3848084. PMID: 35237379; PMCID: PMC8885183.
60.    Majerik V., Horvath G., Charbit G., Badens E., Szokonya L., Bosc N., Teillaud E. Novel particle engineering techniques in drug delivery: review of formulations using supercritical fluids and liquefied gases, Hun. J. Ind. Chem. 2004; 32; 41 56.
61.    Junyaprasert VB, Singhsa P and Jintapattanakit A. Influence of chemical penetration enhancers on skin permeability of Ellagic acid- loaded niosomes. Asian Journal of Pharmaceutical Sciences. 2013; 8; 110- 117.
62.    Li B, Harich K, Wegiel L, Taylor LS, Edgar KJ. Stability and solubility enhancement of ellagic acid in cellulose ester solid dispersions. CarbohydrPolym. 2013; 92(2): 1443-50. doi: 10.1016/j.carbpol.2012.10.051.  
63.    Zuccari G., Baldassari S., Ailuno G., Turrini F., Alfei S. and Caviglioli, Gabriele. (2020). Formulation Strategies to Improve Oral Bioavailability of Ellagic Acid. Appl. Sci. 2020; 10: 3353. DOI- 10.20944/preprints202004.0100.v1.
64.    Sharma, K., Kadian, V., Kumar, A. et al. Evaluation of solubility, photostability and antioxidant activity of ellagic acid cyclodextrinnanosponges fabricated by melt method and microwave-assisted synthesis. J Food SciTechnol. 2022; 59: 898–908. DOI- 10.1007/s13197-021-05085-6.

Recomonded Articles:

Author(s): Swapnil T. Deshpande, P. S. Vishwe, Rohit D. Shah, Swati S. Korabu, Bhakti R. Chorghe, DG Baheti

DOI:         Access: Open Access Read More

Author(s): Dipti G. Phadtare, Amol R. Pawar, R.B. Saudagar, Govind K.Patil

DOI: 10.5958/0975-4377.2017.00002.7         Access: Open Access Read More

Author(s): Kritika Kanoujia, Chandraprabha Dewangan, Ayushi Masih, Dipti Sinha, Divya Oraon, Manisha Jaiswal, Monika Sahu, Ranjeeta Kumari, Sapna Pradhan, Ravi Suman, Rajkishan Dewangan, Roman Banjare, Pradeep Paikra, Mukesh Rawtiya, Mukta Agrawal, Ajazuddin, D. K. Tripathi, Amit Alexander

DOI: 10.5958/0975-4377.2018.00015.0         Access: Open Access Read More

Author(s): Chirag A. Patel, Priyal R. Patel, Dhrubo Jyoti Sen,Jayvadan K. Patel

DOI:         Access: Open Access Read More

Author(s): Patil Namrata D., Gondkar S.B., Saudagar R.B.

DOI: 10.5958/0975-4377.2016.00033.1         Access: Open Access Read More

Author(s): Hardik B. Rana, Kajol Patel, Mansi Dholakia, Vaishali T. Thakkar, Mukesh C. Gohel, Tejal R. Gandhi

DOI: 10.5958/0975-4377.2017.00006.4         Access: Open Access Read More

Author(s): Ashok Thulluru, K. Saravanakumar, Ch. S. Phani Kumar, Nawaz Mahammed, D. Sreeja, G. Bhuvanesh, N. Vamsi Chowdary, Nayeema Khowser Shaik

DOI: 10.5958/0975-4377.2019.00049.1         Access: Open Access Read More

Author(s): Varsha R. Sandhan, S.B. Gondkar, R. B. Saudagar

DOI:         Access: Open Access Read More

Author(s): Suresh A. Marnoor

DOI:         Access: Open Access Read More

Author(s): Sushant R. Jagtap, D.G Phadtare, R.B. Saudagar

DOI: 10.5958/0975-4377.2016.00021.5         Access: Open Access Read More

Author(s): Saikumar Y., Saikishore V., Pavani K., Sairam D.T., Sindhura A.

DOI:         Access: Open Access Read More

Author(s): Masheer Ahmed Khan

DOI:         Access: Open Access Read More

Author(s): Sandeep Gupta, Dheeraj Ahirwar, Neeraj K Sharma, Deenanath Jhade

DOI:         Access: Open Access Read More

Author(s): Shoaib Ahmad

DOI: 10.5958/0975-4377.2016.00041.0         Access: Open Access Read More

Author(s): Shivi Sondhi, Navdeep Singh, Kamya Goyal, Shammy Jindal

DOI: 10.5958/0975-4377.2021.00003.3         Access: Open Access Read More

Author(s): V. Saikishore, G. Srikanth, Ch. Pooja, Y. Mrudula, R. Pavani, Ch. Jyosthna , C. Mayuren

DOI:         Access: Open Access Read More

Author(s): Swati Rawat, Shradha Sangali, Akhilesh Gupta

DOI: 10.5958/0975-4377.2018.00001.0         Access: Open Access Read More

Research Journal of Pharmaceutical Dosage Forms and Technology (RJPDFT) is an international, peer-reviewed journal, devoted to pharmaceutical sciences. ...... Read more >>>

RNI: Not Available                     
DOI: 10.5958/0975-4377 

Recent Articles